Mothershead v. Wofford

CourtDistrict Court, W.D. Washington
DecidedAugust 22, 2024
Docket3:21-cv-05186
StatusUnknown

This text of Mothershead v. Wofford (Mothershead v. Wofford) is published on Counsel Stack Legal Research, covering District Court, W.D. Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mothershead v. Wofford, (W.D. Wash. 2024).

Opinion

1 2 3 4

5 6 7 UNITED STATES DISTRICT COURT 8 WESTERN DISTRICT OF WASHINGTON AT SEATTLE 9 10 JENNIFER LYNN MOTHERSHEAD, CASE NO. C21-5186 MJP 11 Petitioner, ORDER DENYING PETITION FOR HABEAS CORPUS 12 v. 13 DEBORAH J. WOFFORD, 14 Respondent. 15 16 This matter comes before the Court on Petitioner’s Petition for Habeas Corpus (Dkt. No. 17 1) and Motion to Strike (Dkt. No. 96). Having reviewed Petitioner’s Brief on Remaining Claims 18 (Dkt. No. 89), the Motion to Strike (Dkt. No. 96), the Answer to Petitioner’s Brief on Remaining 19 Claims (Dkt. No. 90), the Reply (Dkt. No. 92), and all supporting materials, the Court DENIES 20 the Petition. 21 BACKGROUND 22 Through her § 2254 habeas petition, Petitioner Jennifer Lynn Mothershead argues that 23 she received ineffective assistance of counsel in violation of the Sixth Amendment and asks that 24 1 her conviction be vacated. Mothershead was found guilty of child abuse in the first degree and 2 sentenced to 480 months in prison. At trial, the State presented circumstantial evidence from 3 both fact and expert witnesses that Mothershead had adulterated prescription eye drops with 4 bleach and administered them to her young daughter. Mothershead contends that her trial counsel

5 provided ineffective assistance because she did not retain Dr. Richard Pleus, a toxicologist, to 6 provide his expert opinion critical of the State’s experts, and that she relied solely on cross- 7 examination to defend her client. 8 The Court previously granted Mothershead’s request to pursue an evidentiary hearing to 9 develop Pleus’s testimony to resolve her ineffective assistance claim. (Dkt. No. 65.) But the 10 Ninth Circuit reversed the Court’s decision, holding that Mothershead’s petition “is subject to 11 review under § 2254(d)” and that “[r]eview under § 2254(d) is limited to the state court record.” 12 (Ninth Circuit Memorandum at 2 (Dkt. No. 83).) On remand, the Court set a case schedule for 13 the Parties to brief Mothershead’s remaining claims in light of the Ninth Circuit’s decision. 14 Below, the Court reviews the trial and post-convictions proceedings and the proceedings before

15 this Court. 16 A. Mothershead’s Trial 17 In 2012, the State of Washington charged Mothershead with first-degree assault of a 18 child—her one-year-old daughter, KM. The State’s believed that Mothershead had added bleach 19 to tobramycin eyedrops prescribed by KM’s doctors and gave them to her over a period of 20 months. The State’s case relied extensively on medical opinions and expert toxicologists to 21 support the theory that Mothershead had adulterated the drops with bleach. 22 When Mothershead’s case was assigned to attorney Jane Pierson, a seasoned public 23 defender, little to no investigation had been completed. (Declaration of Jane C. Pierson ¶¶ 1, 4-5

24 1 (Dkt. No. 13 at 166-67).) With the help of an investigator, Pierson identified Dr. Richard Pleus, a 2 “pharmacologist/toxicologist with a post-doctoral specialization in neuropharmacology and 3 experience as a lecturer in eye toxicology.” (Id. ¶ 10.) Pierson obtained funding for and retained 4 Pleus to “evaluate the data underlying the prosecution’s scientific claims that the suspect eye

5 drops were adulterated and caused injury to . . . Mothershead’s daughter[.]” (Id. at ¶ 11.) Pleus 6 was given the laboratory data from both the Washington State Patrol (WSP) Crime Laboratory 7 and the Food and Drug Administration (FDA) Laboratory and Mothershead’s daughter’s medical 8 records and other records describing “the history of the case.” (Id.) 9 Pleus provided a letter and memorandum to Pierson in mid-May 2013, outlining his 10 initial opinions. (Pierson Decl. ¶ 12; Pleus Memorandum (Dkt. No. 13 at 173).) In his Memo, 11 Pleus wrote: 12 You have asked me to evaluate whether claims made by the Plaintiff (the State of Washington) that alleged exposures to adulterated medication resulted in the adverse 13 health effects observed in the Defendant’s daughter, K M . To do so, I have reviewed information you have provided, including forensic laboratory data, medical records, 14 diagnoses, and objective observations, including signs, symptoms, and medical tests performed by or under the direction of a physician. I have also conducted independent 15 research and compared and contrasted those data with data in the toxicological literature. 16 More specifically, I have analyzed the forensic laboratory reports from the Washington State Crime Lab and the FDA Forensic Chemistry Center. In addition, I have reviewed 17 the medical records regarding KM's condition and prescribed medication. All court documents and witness statements have been reviewed as well. 18 My initial opinion, subject to completing my research thoroughly, is that the data 19 provided to me does not scientifically support the Plaintiff’s case that the medication that was administered to K M caused the adverse effects that are reported in the medical 20 records. I have considered a number of possible scenarios, including that Ms. Mothershead did adulterate the medication. 21 (Dkt. No. 13 at 173.) In June 2013, Pleus sent a follow-up letter reiterating the same “initial 22 opinion,” and proposing to complete his analysis and assessment and draft a report. (Dkt. No. 13 23 at 174-75.) Dr. Pleus requested $8,000 to complete this work. (Id. at 175.) 24 1 Pierson’s request for approval of Pleus’s additional work was denied by the Department 2 of Assigned Counsel and she did not request Pleus or any other expert to help her prepare to 3 cross-examine the State’s medical and forensic scientific expert witnesses. (Pierson Decl. ¶¶ 14, 4 16.) At trial, Pierson presented no expert testimony on Mothershead’s behalf. Pierson has

5 explained in a post-trial declaration that her “failure to seek additional funding for Dr. Pleus to 6 complete his work was not a strategic decision.” (Id. at 19.) She also averred that at some point 7 after trial she “learned that [she] misinterpreted Dr. Pleus’ initial opinion” as “referring to data 8 from the compounding pharmacy” when he was actually referring to lab data from the FDA and 9 WSP Crime Lab. (Id.) After trial Pierson came to believe that “Dr. Pleus’s initial opinion 10 constituted exculpatory evidence that [she] possibly could have offered in Ms. Mothershead’s 11 defense.” (Id.) She avers that “[h]ad [she] correctly understood the import of Dr. Pleus’s initial 12 opinion, [she] would have more vigorously sought additional funding to complete Dr. Pleus’s 13 work.” (Id.) 14 At trial, the State presented testimony from ten physicians involved in KM’s treatment,

15 who testified about her eye condition, the unsuccessful efforts to diagnose and treat her, and the 16 causes they considered to explain KM’s symptoms. (In re Pers. Restraint Pet. of Mothershead, 17 No. 51119-3-II, Unpublished Opinion at 4-5 (Wash. Ct. App. Div. II May 19, 2020) (Dkt. No. 13 18 at 188-207) (“Mothershead I”). Five forensic chemists from the FDA “testified about the 19 chemical composition of the tobramycin eye drops” and “agreed that KM’s eye drops contained 20 chloride, a by-product that would be expected if the eye drops had been contaminated by 21 bleach.” (Id. at 5.) But as Respondent concedes, the “prosecution had no direct evidence 22 establishing that Mothershead herself had contaminated the eye drops with bleach which meant 23 that the prosecution had to rely on circumstantial evidence to establish the critical link between

24 1 Mothershead and crime the prosecutor herself described as ‘unthinkable.’” (Answer at 18 (Dkt. 2 No. 90).) 3 At trial, Pierson sought to undermine the State’s conclusions that a foreign substance had 4 been added to the tobramycin drops and that someone else had tampered with the drops.

5 (Mothershead I at 5.) Mothershead testified at trial, but she was not asked to deny that she 6 tampered with the drops.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Porter v. McCollum
558 U.S. 30 (Supreme Court, 2009)
Wong v. Belmontes
558 U.S. 15 (Supreme Court, 2009)
Strickland v. Washington
466 U.S. 668 (Supreme Court, 1984)
Yarborough v. Alvarado
541 U.S. 652 (Supreme Court, 2004)
Harrington v. Richter
131 S. Ct. 770 (Supreme Court, 2011)
Victor Eugene Rios v. Teresa Rocha, Warden
299 F.3d 796 (Ninth Circuit, 2002)
Kenneth Hibbler v. James Benedetti
693 F.3d 1140 (Ninth Circuit, 2012)
Marshall v. Rodgers
133 S. Ct. 1446 (Supreme Court, 2013)
In Re Davis
101 P.3d 1 (Washington Supreme Court, 2004)
Yun Liao v. Maurice Junious
817 F.3d 678 (Ninth Circuit, 2016)
Dwight Tamplin, Jr. v. William Muniz
894 F.3d 1076 (Ninth Circuit, 2018)
In re the Personal Restraint of Davis
152 Wash. 2d 647 (Washington Supreme Court, 2004)
In re the Personal Restraint of Khan
184 Wash. 2d 679 (Washington Supreme Court, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Mothershead v. Wofford, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mothershead-v-wofford-wawd-2024.